Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Novo Nordisk Stock Jumps After Earnings. Compounding Market’s Growth Took it By Surprise
Novo Nordisk Stock Jumps After Earnings. Compounding Market’s Growth Took it By Surprise · Barrons.com

In This Article:

The Danish drugmaker now expects sales growth between 13% and 21%, down from a previous range of 16% to 24%.